Country Medical Lead, Rare Diseases

This role is considered Virtual.

1964: Country Medical Lead – Rare Diseases

Location: UK – Field-based

Travel: 50-60%

Are you a passionate Medical Affairs professional eager to make a difference in rare diseases? Do you thrive in an innovative, science-driven environment where bold ideas and collaboration fuel progress?

At Alnylam, we are transforming the future of medicine with RNAi technology, delivering groundbreaking treatments to patients with unmet needs. As Country Medical Lead, you’ll play a pivotal role in driving medical strategy, engaging with key opinion leaders (KOLs), and shaping the future of rare disease management.

About The Role

The Medical Affairs Lead is a scientific and clinical expert that strategically drives and supports the medical objectives of Alnylam in the area of rare diseases (AHP&PH1).

You will be accountable to communicate the science and clinical application of RNAi to Healthcare Practitioners (HCPs). You will provide support to all functions within the Country to ensure achievement of local objectives, in close collaboration with Global Medical Affairs to maximize patient outcomes by setting and continuously advancing the evidence-based medical standard of care.

In addition, you’ll build strong cross-functional relationships with colleagues in Medical Affairs, Clinical Research, R&D, Patient Advocacy and Commercial Operations, while maintaining full compliance with all relevant company, industry, legal, and regulatory requirements.

The successful candidate will be UK-based and cover both UK (90%) and Nordics (10%).

Why Join Us?

• Impactful Work – Be at the forefront of rare disease advancements
• Innovative Culture – Work with a team that values bold ideas and scientific excellence
• Collaborative Environment – Engage with cross-functional teams in Medical Affairs, R&D, Clinical, and Market Access
  
  

Primary Duties And Responsibilities

• Develop and implement a strategic Country Medical Affairs Plan
• Cultivate peer-to-peer relationships with healthcare professionals & KOLs
• Lead medical education initiatives, including symposia and advisory boards
• Provide scientific expertise to cross-functional teams and external stakeholders
• Support market access discussions on burden of illness and clinical trial data
• Ensure compliance with ABPI and IPHA Codes of Practice (Final Signatory required)
  
  

What You Bring

• UK-registered MD and/or UK-registered Pharmacist with Medical Affairs experience Final Signatory status under ABPI/IPHA
• Excellent fluent and verbal English
• Strong scientific & clinical expertise in rare diseases (preferred) Excellent analytical, communication & stakeholder engagement skills
• Authorization for material signature Code of Practice and ABPI in UK
  
  

If you’re ready to push boundaries, challenge the status quo, and transform patient outcomes, apply now and join us on this journey of medical innovation!

Next Steps

The closing date of this vacancy is Sunday, 20 th April however, we welcome your application as soon as possible.

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.